medigraphic.com
ISSN 2305-7939 (Electronic)

2018, Number 2

<< Back Next >>

RCU 2018; 7 (2)

Epidemiological characteristics, presentation forms and therapeutic behavior in renal tumors

Casado MPR, Méndez LVC, Trevín FG, Santos FRS, Méndez JO, Ferrer MCE

Language: Spanish
References: 22
Page: 89-98
PDF size: 778.00 Kb.


ABSTRACT

Introduction: Since the first report of a renal tumor was published more than 175 years ago, doctors and scientists have been interested in recognizing its different variants. Objective: To determine the epidemiological characteristics, diagnostic and therapeutic strategy, as well as the anatomopathological findings of patients with renal tumors. Methods: A retrospective, observational and descriptive study was conducted to a total of 372 patients with renal tumors from 2012 to 2016 at "Celia Sánchez" and "Carlos Manuel de Céspedes" Hospitals, Granma province. Results: The average age of the patients was 62.6 years old; 63.97 % were males. The 58.07 % presented at least one risk factor. The diagnosis was incidental in 80.91 % of the patients; 47.04 % of the tumors measured up to 40 mm; 12.63 % of the patients had metastases, while 90.86 % of the tumors were resected. 68.34% of the resected tumors underwent total nephrectomy. The most frequent histological tumor type was renal cell carcinoma (96.23 %), specifically the clear cells subtype (79.83 %). Conclusions: Renal tumors still have an incidental diagnosis in initial pathological stages having an eminently surgical therapeutic strategy at the expense of radical renal surgeries.


REFERENCES

  1. Santana Pérez JL, Rodríguez Pastoriza R, León Méndez D. Hipernefroma gigante. Presentación de un caso. MEDICIEGO. 2016 [citado 2017 Jul 07];22(1):53-8. Disponible en: http://www.revmediciego.sld.cu/index.php/me diciego/article/view/183

  2. Otunctemur A, Dursun M, Ozer K, Horsanali O, Ozbek E. Renal Cell Carcinoma and Visceral Adipose Index: a new risk parameter. Int Braz J Urol. 2016 [citado 2017 Jul 07];(1). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/275321 15

  3. Costabel J, García Marchiñena J, Uría L, Tirapegui S, Jurado A, Gueglio G. Formas actuales de presentación del tumor renal. MEDICINA (Buenos Aires). 2015 [citado 2017 Jul 07];75:159-62. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_ arttext&pid=S0025-76802015000300005

  4. Quiroga Matamoros W, Fernández F, Citarella Otero D, Rangel J, Estrada Guerrero A, Patiño ID. Guía de manejo del carcinoma de células renales. Urol Colomb. 2016 [citado 2017 Jul 07];25(2):169-89. Disponible en: http://www.redalyc.org/articulo.oa?id=149146 287016

  5. Springer Pérez PM, Suárez Sori B, Figueredo García O, Torres Lebrato L. Caracterización histológica del carcinoma de células renales. Rev Arch Med Camagüey. 2017 [citado 2017 Jul 07];21(4):452-60. Disponible en: www.revistaamc.sld.cu/index.php/amc/article/ view/5149/2760

  6. Bulnes Vázquez V, Álvarez Múgica M, Fernández Gómez JM, Nava Tomás E, Jalón Monzón A, Meilán Martínez Á. Características clínico-patológicas del carcinoma de células renales detectado incidentalmente mediante estudios radiológicos. Actas Urol Esp. 2008 [citado 2017 Jul 07];32(10). Disponible en: http://scielo.isciii.es/scielo.php?script=sci_artte xt&pid=S0210-48062008010000005&nrm=iso

  7. Alghamdi A, Alkhateeb S, Alghamdi K, Bazarbashi S, Murshid E, Alotaibi M, et al. Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for renal cell carcinoma. Urol Ann. 2016 [citado 2017 Jul 07];8(2). Available from: http://www.ncbi.nlm.nih.gov/pubmed/271411 80

  8. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, et al. Prognostic value of histological subtypes in renal cell carcinoma: A multicenter experience. J Clin Oncol. 2005 [citado 2017 Jul 07];23:2763-71. Available from: http://refhub.elsevier.com/S0120- 789X(16)00034-4/sbref0245

  9. Giménez Bachs JM, Donate Moreno MJ, Salinas Sánchez AS, Pastor Navarro H, Carrión López P, Pastor Guzmán JM, et al. Supervivencia en relación a los factores pronóstico en una serie de pacientes con carcinoma de células renales. Arch Esp Urol. 2007 [citado 2017 Jul 07];60(10). Disponible en: http://scielo.isciii.es/scielo.php?script=sci_artte xt&pid=S0004-06142007010000004&nrm=iso

  10. Capitanio U, Cloutier V, Zini L, Isbarn H, Jeldres C, Shariat SF, et al. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: A population based study. BJU Int. 2009 [citado 2017 Jul 07];103:1496-500. Available from: http://refhub.elsevier.com/S0120- 789X(16)00034-4/sbref0250

  11. Venniyoor A, EssamAM, Ramadhan F, Keswani H, Mehdi I, Bahrani BA. High Occurrence of Non-Clear Cell Renal Cell Carcinoma in Oman. Asian Pac J Cancer Prev. 2016 [cited 2017 Jul 07];17(6). Available from: http://www.ncbi.nlm.nih.gov/pubmed/273566 93

  12. Chacón Garita L, Moreira Carvajal M. Carcinoma de células renales: descripción de casos. Acta méd costarric. 2015 [citado 2017 Jul 07];57(3):113-6. Disponible en: http://actamedica.medicos.cr/index.php/Acta_ Medica/article/view/887/805

  13. Yang G, Villalta JD, Meng MV, et al. Evolving practice patterns for the management of small renal masses in the USA. BJU Int. 2012;110:1156-61.

  14. Haake SM, Weyandt JD, Rathmell WK. Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas. Mol Cancer Res. 2016 [cited 2017 Jul 07];14(7). Available from: http://www.ncbi.nlm.nih.gov/pubmed/273301 05

  15. Vásquez Gijón M, Rodríguez Nava P, Dena Espinoza E, Morales Pérez F. Caracterización de tumores renales por tomografía computada multicorte y su concordancia anatomopatológica. Propuesta de reporte estructurado. Anales de Radiología México. 2016 (Revisado en mayo 2017);15(2):140-147. Disponible en: http://www.medigraphic.com/pdfs/anaradmex /arm-2016/arm162h.pdf

  16. Mueller Lisse UG, Mueller Lisse UL. Imaging of advanced renal cell carcinoma. World J Urol. 2010 [cited 2017 Jul 07];28:253-61. Available from: http://refhub.elsevier.com/S0120- 789X(16)00034-4/sbref0140

  17. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J. 2013;63:11-30.

  18. García García A, Guerra Román FB, García Morales I. Enucleación simple en el tratamiento de los tumores renales. Revista Cubana de Urología. 2017 [citado 2017 Jul 07];6(1):14-27. Disponible en: http://www.medigraphic.com/pdfs/revcuburol/ rcu-2017/rcu171c.pdf

  19. García A, González T. Simple Enucleation for Renal Tumors: Indications, Techniques, and Results. Curr Urol Rep. 2016 (Revisado en enero 2017);17:1-7. Disponible en: www.revurologia.sld.cu/index.php/rcu/article/v iew/285/328

  20. Minervini A, Serni S, Tuccio A, Raspollini MR, Di Cristofano C, Siena G, et al. Local recurrence after tumor enucleation for renal cell carcinoma with no ablation of the tumor bed: results of a prospective single-centre study. BJU International. 2010 [cited 2017 Jul 07];107. Available from: http://dx/doi:10.1111/j.1464- 410X.2010.09949.x

  21. Minervini A, Serni S, Tuccio A, Siena G, Vittori G, Masieri L, et al. Simple Enucleation Versus Radical Nephrectomy in the Treatment of pT1a and pT1b Renal Cell Carcinoma. Ann Surg Oncol. 2012 [citado 2017 Jul 07];19. Available from: http://dx/doi.10.1245/s10434-011-2003-x

  22. Minervini A, Tuccio A, Masieri L, Veneziano D, Vittori G, Siena G, et al. Endoscopic robot assisted simple enucleation (ERASE) for clinical T1 renal masses: description of the technique and early postoperative results. Surg Endosc. 2015 (Revisado en mayo 2017);29(5):1241-9. Disponible en: https://link.springer.com/content/pdf/10.1007 %2Fs00464-014-3807-0.pdf




2020     |     www.medigraphic.com